Product Images Cephalexin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Cephalexin NDC 57297-121 by Lupin Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image-01 - db58498b ab09 4707 9bf4 2db878ace430 01

image-01 - db58498b ab09 4707 9bf4 2db878ace430 01

Image - db58498b ab09 4707 9bf4 2db878ace430 02

Image - db58498b ab09 4707 9bf4 2db878ace430 02

This is a description of a medication called Cephalexin, which comes in the form of capsules with strength of 250mg anhydrous Cephalexin. The medication is manufactured by Lupin Pharmaceuticals, USA. The usual adult dose is one capsule every 6 hours, and in severe cases, the dose may be increased up to 4g per day. It is advised to store the medication in a tight, light-resistant container, and keep it closed. The accompanying literature should be referred to for more information. The text also includes the manufacturer's address and a batch number.*

Image - db58498b ab09 4707 9bf4 2db878ace430 03

Image - db58498b ab09 4707 9bf4 2db878ace430 03

NDC 68180-122-01 is a prescription drug that is usually prescribed for adults with a dose of 250 mg every 6 hours. In severe infections, the dose may be increased up to 4 g per day. The drug comes in capsules with a potency equivalent to 500 mg of anhydrous cephalexin USP. It is important to store the drug in a light-resistant container at a temperature of 20℃ to 25℃. This drug is manufactured in India by Lupin and for further details, you should refer to the accompanying literature.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.